AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.27 billion. The enterprise value is $3.17 billion.
| Market Cap | 1.27B |
| Enterprise Value | 3.17B |
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 132.36 million shares outstanding. The number of shares has increased by 2.09% in one year.
| Current Share Class | 132.36M |
| Shares Outstanding | 132.36M |
| Shares Change (YoY) | +2.09% |
| Shares Change (QoQ) | +1.69% |
| Owned by Insiders (%) | 7.99% |
| Owned by Institutions (%) | 81.61% |
| Float | 89.63M |
Valuation Ratios
The trailing PE ratio is 17.68 and the forward PE ratio is 9.55.
| PE Ratio | 17.68 |
| Forward PE | 9.55 |
| PS Ratio | 0.41 |
| Forward PS | 0.38 |
| PB Ratio | 0.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.58 |
| P/OCF Ratio | 2.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.03, with an EV/FCF ratio of 13.71.
| EV / Earnings | 42.98 |
| EV / Sales | 0.98 |
| EV / EBITDA | 5.03 |
| EV / EBIT | 12.09 |
| EV / FCF | 13.71 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.22.
| Current Ratio | 1.06 |
| Quick Ratio | 0.75 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | 8.43 |
| Interest Coverage | 2.24 |
Financial Efficiency
Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is 4.51%.
| Return on Equity (ROE) | 5.51% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 4.51% |
| Return on Capital Employed (ROCE) | 7.03% |
| Revenue Per Employee | $308,644 |
| Profits Per Employee | $7,025 |
| Employee Count | 10,500 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 18.64 |
Taxes
In the past 12 months, AdaptHealth has paid $64.12 million in taxes.
| Income Tax | 64.12M |
| Effective Tax Rate | 42.97% |
Stock Price Statistics
The stock price has decreased by -2.53% in the last 52 weeks. The beta is 1.59, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -2.53% |
| 50-Day Moving Average | 9.16 |
| 200-Day Moving Average | 9.54 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 1,230,028 |
Short Selling Information
The latest short interest is 10.39 million, so 7.85% of the outstanding shares have been sold short.
| Short Interest | 10.39M |
| Short Previous Month | 11.30M |
| Short % of Shares Out | 7.85% |
| Short % of Float | 11.59% |
| Short Ratio (days to cover) | 8.84 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.24 billion and earned $73.76 million in profits. Earnings per share was $0.54.
| Revenue | 3.24B |
| Gross Profit | 699.42M |
| Operating Income | 262.25M |
| Pretax Income | -730.11M |
| Net Income | 73.76M |
| EBITDA | 630.25M |
| EBIT | 262.25M |
| Earnings Per Share (EPS) | $0.54 |
Balance Sheet
The company has $70.21 million in cash and $1.95 billion in debt, giving a net cash position of -$1.88 billion or -$14.20 per share.
| Cash & Cash Equivalents | 70.21M |
| Total Debt | 1.95B |
| Net Cash | -1.88B |
| Net Cash Per Share | -$14.20 |
| Equity (Book Value) | 1.59B |
| Book Value Per Share | 12.00 |
| Working Capital | 35.91M |
Cash Flow
In the last 12 months, operating cash flow was $552.34 million and capital expenditures -$321.14 million, giving a free cash flow of $231.20 million.
| Operating Cash Flow | 552.34M |
| Capital Expenditures | -321.14M |
| Free Cash Flow | 231.20M |
| FCF Per Share | $1.75 |
Margins
Gross margin is 21.58%, with operating and profit margins of 8.09% and 2.49%.
| Gross Margin | 21.58% |
| Operating Margin | 8.09% |
| Pretax Margin | 4.60% |
| Profit Margin | 2.49% |
| EBITDA Margin | 19.45% |
| EBIT Margin | 8.09% |
| FCF Margin | 7.13% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.09% |
| Shareholder Yield | -2.09% |
| Earnings Yield | 5.72% |
| FCF Yield | 17.91% |
Analyst Forecast
The average price target for AdaptHealth is $13.40, which is 40.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.40 |
| Price Target Difference | 40.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 6.22% |
| EPS Growth Forecast (5Y) | 5.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 6 |